PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Secukinumab in plaque psoriasis: Manufacturer dossier provided no hint of an added benefit

Partly lack of suitable data, partly no relevant differences between the treatment groups

2015-09-08
(Press-News.org) Secukinumab (trade name: Cosentyx) has been approved since January 2015 for adults with moderate to severe plaque psoriasis. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however: In patients who are candidates for systemic treatment, an indirect comparison provided no suitable data because the minimum study duration had not been reached. In adults in whom other systemic treatments have been unsuccessful or unsuitable, the results from a direct comparison showed no statistically significant differences in comparison with the comparator group.

Study duration too short

The drug manufacturer presented an indirect comparison with methotrexate as comparator therapy for adults with plaque psoriasis who are candidates for systemic treatment and/or phototherapy. Placebo was used as common comparator.

A chronic condition such as moderate to severe plaque psoriasis requires longterm treatment. Studies with a minimum duration of 24 weeks are therefore needed to assess an added benefit. However, the five studies on secukinumab treatment presented by the company only lasted 12 weeks each; and the only study on methotrexate treatment lasted only 16 weeks. Hence the manufacturer dossier provided no suitable data and therefore no hint of an added benefit for this patient group.

No relevant group differences

For adults with plaque psoriasis for whom systemic treatment is not an option or in whom it has been unsuccessful, the manufacturer compared secukinumab with ustekinumab. It presented data of a total of 313 patients after a treatment duration of 24 weeks from an ongoing study for this comparison. However, there were no statistically significant differences between the treatment groups, neither regarding remission nor regarding symptoms and complaints or severe side effects and treatment discontinuations due to adverse events. Regarding the effect of the treatment on quality of life, the manufacturer presented data after a study duration of 16 weeks. These were unsuitable for the assessment because the study duration was too short. Hence no added benefit resulted from the manufacturer dossier for this patient group either.

INFORMATION:

G-BA decides on the extent of added benefit

This dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the Federal Joint Committee (G-BA). After publication of the dossier assessment, the G-BA conducts a commenting procedure and makes a final decision on the extent of the added benefit.

An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the Website gesundheitsinformation.de, published by IQWiG, provides easily understandable German-language Information.

More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.



ELSE PRESS RELEASES FROM THIS DATE:

Indications of the origin of the Spin Seebeck effect discovered

2015-09-08
This news release is available in German. The recovery of waste heat in all kinds of processes poses one of the main challenges of our time to making established processes more energy-efficient and thus more environmentally friendly. The Spin Seebeck effect (SSE) is a novel, only rudimentarily understood effect, which allows for the conversion of a heat flux into electrical energy, even in electrically non-conducting materials. A team of physicists at Johannes Gutenberg University Mainz (JGU), the University of Konstanz, TU Kaiserslautern, and the Massachusetts Institute ...

WSU researchers create super-stretchable metallic conductors for flexible electronics

2015-09-08
PULLMAN, Wash.--Washington State University researchers have discovered how to stretch metal films used in flexible electronics to twice their size without breaking. The discovery could lead to dramatic improvements and addresses one of the biggest challenges in flexible electronics, an industry still in its infancy with applications such as bendable batteries, robotic skins, wearable monitoring devices and sensors, and connected fabrics. The work was led by Rahul Panat and Indranath Dutta, researchers in Voiland College's School of Mechanical and Materials Engineering, ...

Survey reinforces further understanding of dietary deficiencies and optimum nutrition needed

2015-09-08
September 8, 2015, New York, New York- Data from a three-country survey seeking to understand beliefs of adults on the role of diet for optimal health, as well as consumption of key micronutrients including Omega-3 and Vitamin D, will be published in the November/December issue of Nutrition Today. The survey of 3,000 American, British and German adults found that 72 percent reported having a "healthy" or "optimal" diet and more than half (52 percent) believed they consume all the key nutrients needed for optimal nutrition through food sources alone. However, the prevalence ...

Reviving extinct Mediterranean forests, urban land-sparing, ocean noise pollution

2015-09-08
Extinct Mediterranean forests of biblical times could return and thrive in warmer, drier future. The Mediterranean has cradled humanity and our cities, farms, domesticated animals, and logging habits for many thousands of years. During the last 5 to 8 millennia, as people developed farming and settled in cities, the landscape has gradually changed from a thick canopy of trees to open grass and shrubs. The ghosts of Sicily's extinct evergreen forests of holm oak (Quercus ilex) and olive trees (Olea europaea) remain in the record of pollen left in the lakebed sediments. ...

Brain damage during stroke may point to source of addiction

2015-09-08
A pair of studies suggests that a region of the brain - called the insular cortex - may hold the key to treating addiction. Scientists have come to this conclusion after finding that smokers who suffered a stroke in the insular cortex were far more likely to quit smoking and experience fewer and less severe withdrawal symptoms than those with strokes in other parts of the brain. "These findings indicate that the insular cortex may play a central role in addiction," said Amir Abdolahi Ph.D., M.P.H., lead author of the studies. "When this part of the brain is damaged during ...

Biomarker helps predict survival time in gastric cancer patients

2015-09-08
Philadelphia, PA, September 8, 2015 - Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role played by the biomarker microRNA (miR)-506 in gastric cancer. Patients whose primary gastric cancer lesions express high levels of miR-506 have significantly longer survival times compared to patients with low miR-506 expression. In addition, miR-506 suppresses tumor growth, blood vessel formation, and metastasis. "Epithelial-to-mesenchymal ...

Policy recommendations for use of telemedicine in primary care

2015-09-08
1. ACP recommends policies for practicing telemedicine in primary care Free: http://www.annals.org/article.aspx?doi=10.7326/M15-0498 Editorial: http://www.annals.org/article.aspx?doi=10.7326/M15-1416 URLs go live when embargo lifts In a new position paper, the American College of Physicians (ACP) says that telemedicine can improve access to care, but policies are needed to balance the benefits and risks for both patients and physicians. The authors note that conscious scrutiny is especially important as policymakers and stakeholders shape the landscape for ...

Ancient genomes link early farmers to Basques

Ancient genomes link early farmers to Basques
2015-09-07
An international team led by researchers at Uppsala University reports a surprising discovery from the genomes of eight Iberian Stone-Age farmer remains. The analyses revealed that early Iberian farmers are the closest ancestors to modern-day Basques, in contrast previous hypotheses that linked Basques to earlier pre-farming groups. The team could also demonstrate that farming was brought to Iberia by the same/similar groups that migrated to northern and central Europe and that the incoming farmers admixed with local, Iberian hunter-gather groups, a process that continued ...

'Clever adaptation' allows yeast infection fungus to evade immune system attack

2015-09-07
Johns Hopkins Bloomberg School of Public Health researchers say they have discovered a new way that the most prevalent disease-causing fungus can thwart immune system attacks. The findings, published Sept. 7 in the Proceedings of the National Academy of Sciences, offer new clues about how Candida albicans, the fungus responsible for vaginal yeast infections and the mouth infection thrush, is able to cause a deadly infection once it enters the bloodstream. When the body is faced with an infection, cells give a burst of free radicals to kill the germs. C. albicans ...

Mobile phone records may predict epidemics of mosquito-borne dengue virus

2015-09-07
Boston, MA -- A new study led by researchers at Harvard T.H. Chan School of Public Health finds that mobile phone records can be used to predict the geographical spread and timing of dengue epidemics. More people around the world are becoming vulnerable to this deadly virus as climate change expands the range of the mosquito that transmits dengue and infected travelers spread the disease across borders. Utilizing the largest data set of mobile phone records ever analyzed to estimate human mobility, the researchers developed an innovative model that can predict epidemics ...

LAST 30 PRESS RELEASES:

Be humble: Pitt studies reveal how to increase perceived trustworthiness of scientists

Promising daily tablet increases growth in children with dwarfism

How 70% of the Mediterranean Sea was lost 5.5 million years ago

Keeping the lights on and the pantry stocked: Ensuring water for energy and food production

Parkinson’s Paradox: When more dopamine means more tremor

Study identifies strategy for AI cost-efficiency in health care settings

NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release

Greg Liu is in his element using chemistry to tackle the plastics problem

Cocoa or green tea could protect you from the negative effects of fatty foods during mental stress - study

A new model to explore the epidermal renewal

Study reveals significant global disparities in cancer care across different countries

Proactively screening diabetics for heart disease does not improve long-term mortality rates or reduce future cardiac events, new study finds

New model can help understand coexistence in nature

National Poll: Some parents need support managing children's anger

Political shadows cast by the Antarctic curtain

Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition

A new discovery about pain signalling may contribute to better treatment of chronic pain

Migrating birds have stowaway passengers: invasive ticks could spread novel diseases around the world

Diabetes drug shows promise in protecting kidneys

Updated model reduces liver transplant disparities for women

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller

‘Teen-friendly’ mindfulness therapy aims to help combat depression among teenagers

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

Kidney outcomes in transthyretin amyloid cardiomyopathy

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction

Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty

Evaluating performance and agreement of coronary heart disease polygenic risk scores

Heart failure in zero gravity— external constraint and cardiac hemodynamics

[Press-News.org] Secukinumab in plaque psoriasis: Manufacturer dossier provided no hint of an added benefit
Partly lack of suitable data, partly no relevant differences between the treatment groups